Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Jansen

Showing results (111-120 of 307) with videos related to

Pageof 31
Sort By:
Digestive Diseases and Sciences|October 1, 1993
Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in manA A Masclee, J B Jansen, L C Rovati, et al.
Scandinavian Journal of Gastroenterology|February 1, 1990
Effect of gastrectomy with either Roux-en-Y or Billroth II anastomosis on small-intestinal functionP N Rieu, J B Jansen, H J Joosten, et al.
Gastroenterology|May 1, 1990
Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymesP Layer, J B Jansen, L Cherian, et al.
Neuroendocrinology|February 1, 1995
Effects of somatostatin on human satietyR J Lieverse, J B Jansen, A M Masclee, et al.
Digestive Diseases and Sciences|March 1, 1994
Effect of synthetic prostaglandin E2 analog enprostil on omeprazole-induced hypergastrinemia and hyperpepsinogenemiaJ L Meijer, L F Crobach, J B Jansen, et al.
Digestion|October 12, 2000
Plasma cholecystokinin, plasma peptide YY and gallbladder motility in patients with slow transit constipation: effect of intestinal stimulationR M Mollen, W P Hopman, H H Kuijpers, et al.
European Journal of Gastroenterology & Hepatology|August 13, 1999
Abnormalities of upper gut motility in patients with slow-transit constipationR M Mollen, W P Hopman, H H Kuijpers, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2001
Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart diseaseR J Laheij, J B Jansen, A L Verbeek, et al.
Clinical Science (London, England : 1979)|September 1, 1993
Bombesin reduces food intake after a preload in man by a cholecystokinin-independent mechanismR J Lieverse, J B Jansen, A A Masclee, et al.
European Journal of Clinical Investigation|April 16, 1998
Release of peptide YY and inhibition of gastric acid secretion by long-chain and medium-chain triglycerides but not by sucrose polyester in menM I Maas, W P Hopman, M B Katan, et al.
Pageof 31

Showing results (111-120 of 307) with videos related to

Sort By:
Pageof 31
Digestive Diseases and Sciences|October 1, 1993
Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in manA A Masclee, J B Jansen, L C Rovati, et al.
Scandinavian Journal of Gastroenterology|February 1, 1990
Effect of gastrectomy with either Roux-en-Y or Billroth II anastomosis on small-intestinal functionP N Rieu, J B Jansen, H J Joosten, et al.
Gastroenterology|May 1, 1990
Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymesP Layer, J B Jansen, L Cherian, et al.
Neuroendocrinology|February 1, 1995
Effects of somatostatin on human satietyR J Lieverse, J B Jansen, A M Masclee, et al.
Digestive Diseases and Sciences|March 1, 1994
Effect of synthetic prostaglandin E2 analog enprostil on omeprazole-induced hypergastrinemia and hyperpepsinogenemiaJ L Meijer, L F Crobach, J B Jansen, et al.
Digestion|October 12, 2000
Plasma cholecystokinin, plasma peptide YY and gallbladder motility in patients with slow transit constipation: effect of intestinal stimulationR M Mollen, W P Hopman, H H Kuijpers, et al.
European Journal of Gastroenterology & Hepatology|August 13, 1999
Abnormalities of upper gut motility in patients with slow-transit constipationR M Mollen, W P Hopman, H H Kuijpers, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2001
Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart diseaseR J Laheij, J B Jansen, A L Verbeek, et al.
Clinical Science (London, England : 1979)|September 1, 1993
Bombesin reduces food intake after a preload in man by a cholecystokinin-independent mechanismR J Lieverse, J B Jansen, A A Masclee, et al.
European Journal of Clinical Investigation|April 16, 1998
Release of peptide YY and inhibition of gastric acid secretion by long-chain and medium-chain triglycerides but not by sucrose polyester in menM I Maas, W P Hopman, M B Katan, et al.
Pageof 31